StocksJazz PharmaceuticalsJAZZ

JAZZ

Jazz Pharmaceuticals

153.49 2.72 (1.80%)
Forsinkede priser fra NASDAQ i USD Marked lukket
Handl
S
153.24
K
153.61
Top
MarketUpdates
Vil $JAZZ (Jazz Pharmaceuticals) s kvartal 2 2022-rapport betyde en ændring i stemningen?
2
AUG
RAPPORTER
Jazz Pharmaceuticals Kv.2 2022 indtjeningsrapport forventes at blive offentliggjort efter markedsåbning
Giv besked
JAZZ
JAZZ
Jazz Pharmaceuticals
153.49
2.72
(1.80%)
Handl
Andrea Antico
Jazz Pharmaceuticals initiated with a Buy at UBS $JAZZ (Jazz Pharmaceuticals) UBS analyst Ashwani Verma initiated coverage of Jazz Pharmaceuticals with a Buy rating and $194 price target as part of a broader research note on U.S. Pharmaceuticals. The company's diversification from childhood epilepsy... Vis Oversæt
MarketUpdates
$JAZZ (Jazz Pharmaceuticals) Q2 2022 earnings report is expected to be released Oversæt
MarketUpdates
$JAZZ (Jazz Pharmaceuticals) Q2 2022 earnings report is expected to be released Oversæt
Medical Marijuana
Dear Investors, Here is your monthly update for May 2022. ❓ This month was mixed for financial markets across the globe, as inflationary worries persisted while the Russia-Ukraine conflict continued to rage. China's zero-covid policy was also in focus. In the US, earnings season carried on while... Vis Oversæt
Synes godt om KommentarDel
Vis flere kommentarer2 af 3
1 svar
null
.